Subscribe

China Boton Group Company Limited (3318.HK)

HKD2.77 -0.03 (-1.07%)
HK HKSE Basic Materials Chemicals - Specialty
Address Wing On House
Central, HK
CEO Ming Fan Wang
IPO 2005-12-09
ISIN KYG2152H1074

Explore sections of this company profile

Description

China Boton Group Company Limited, along with its affiliated entities, specializes in the creation, manufacturing, distribution, and sale of a diverse array of extracts, flavorings, and fragrances. Its operations extend globally, encompassing mainland China, Europe, the United States, and other parts of Asia. The company's business activities are structured into five key divisions: Flavor Enhancers, Food Flavors, Fine Fragrances, Healthcare Products, and Investment Properties. Its flavor products are primarily supplied to manufacturers in sectors such as tobacco, beverages, everyday foodstuffs, preserved foods, savory items, and confectionery. Meanwhile, its fragrance offerings cater to producers of cosmetics, perfumes, soaps, personal care items, hair products, deodorants, cleaning agents, and air fresheners. Additionally, the group is involved in the design, production, and marketing of electronic vaping devices, including both single-use and rechargeable models, as well as associated accessories, which are sold to tobacco firms, independent vape manufacturers, and other clients. Another aspect of its business involves the leasing of its investment real estate. Established in 1991 and headquartered in Central, Hong Kong, the company was formerly known as China Flavors and Fragrances Company Limited until it adopted its current name in June 2020.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
HKD2.77 -0.03 (-1.07%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
592.3K
Beta
-0.27
Float Shares
348.55M
Free Float %
32.3%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+0.00% +9.17% +18.02% -23.39% -26.40% -24.28% -16.56% -45.19% -72.42% -51.48% +11.02%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
2.77
DCF (Unlevered) 1.78 -35.6%
DCF (Levered) 62.64 +2,161.5%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 100% Bullish
Rating 2024-11 Change
Strong Buy 0 0
Buy 1 +1
Hold 0 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
0.75
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
0 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
  • Revenue growth Chemicals - Specialty: +4.7%
    -9.5% Q4'25: -6.5% (vs Q4'23)
  • EPS growth Chemicals - Specialty: +13.2%
    -5,747.1% Q4'25: -1,366.7% (vs Q4'23)
  • FCF margin FCF growth · Chemicals - Specialty: +44.1%
    -3.7% Q4'25: -4.1% (vs Q4'23)
  • EBIT margin Chemicals - Specialty: +8.8%
    -3.7% Q4'25: -7.6% (vs Q4'23)
  • ROIC Chemicals - Specialty: +5.6%
    -2.0% Q4'25: -12.5% (vs Q4'23)
  • Share dilution Chemicals - Specialty: +0.1%
    0.0% Q4'25: 0.0% (vs Q4'23)
  • Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×
    30.46× Q4'25: -43.35× (vs Q4'23)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (-0.25) × ERP
WACC = 35% × Ke + 65% × Kd (4.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Intrinsic value (base): 1.78 Current price: 2.77
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2005
actual
Dec 2006
actual
Dec 2007
actual
Dec 2015
actual
Dec 2016
actual
Dec 2017
actual
Dec 2018
actual
Dec 2019
actual
Dec 2020
actual
Dec 2021
actual
Dec 2022
actual
Dec 2023
actual
Dec 2024
actual
Dec 2025
actual
Dec 2026
1 Rev. Ana.
Revenue
221.67M
est: 212.95M (+4.1%)
292.58M
est: 310.14M (-5.7%)
428.76M
est: 429.40M (-0.1%)
698.20M
est: 683.07M (+2.2%)
963.46M
est: 784.40M (+22.8%)
1.09B
est: 1.10B (-1.3%)
1.15B
est: 934.29M (+22.7%)
1.64B
est: 1.30B (+26.2%)
1.85B
est: 1.46B (+27.1%)
2.29B
est: 2.49B (-8.3%)
2.32B
est: 2.59B (-10.3%)
2.06B
est: 2.73B (-24.4%)
1.65B
est: 2.34B (-29.4%)
1.50B
est: 2.56B (-41.7%)
2.96B
2.96B – 2.96B
+15.4% YoY
EBITDA
82.28M
est: 41.84M (+96.7%)
99.15M
est: 114.93M (-13.7%)
131.91M
est: 134.72M (-2.1%)
148.49M
est: 220.68M (-32.7%)
345.03M
est: 154.11M (+123.9%)
410.97M
est: 216.72M (+89.6%)
393.16M
est: 183.56M (+114.2%)
433.02M
est: 195.55M (+121.4%)
458.38M
est: 286.33M (+60.1%)
493.93M
est: 489.74M (+0.9%)
304.83M
est: 509.13M (-40.1%)
384.14M
est: 364.06M (+5.5%)
333.30M
est: 367.32M (-9.3%)
73.75M
est: 402.28M (-81.7%)
464.27M
464.27M – 464.27M
+15.4% YoY
EBIT
72.01M
est: 27.89M (+158.1%)
93.96M
est: 115.08M (-18.4%)
136.88M
est: 129.75M (+5.5%)
128.08M
est: 212.54M (-39.7%)
269.75M
est: 102.75M (+162.5%)
300.63M
est: 144.49M (+108.1%)
283.52M
est: 122.38M (+131.7%)
304.50M
est: 170.36M (+78.7%)
322.90M
est: 190.90M (+69.1%)
357.62M
est: 326.52M (+9.5%)
171.00M
est: 449.40M (-62.0%)
252.07M
est: 515.27M (-51.1%)
213.53M
est: 207.73M (+2.8%)
-55.58M
est: 227.50M (-124.4%)
262.56M
262.56M – 262.56M
+15.4% YoY
Net Income
59.76M
est: 210.47M (-71.6%)
75.38M
est: 90.55M (-16.8%)
100.55M
est: 104.08M (-3.4%)
71.52M
est: 170.48M (-58.1%)
92.05M
est: 129.53M (-28.9%)
130.11M
est: 207.86M (-37.4%)
127.47M
est: 144.33M (-11.7%)
163.53M
est: 139.89M (+16.9%)
116.62M
est: 206.64M (-43.6%)
183.51M
est: 187.16M (-2.0%)
48.32M
est: 215.83M (-77.6%)
146.37M
est: 206.08M (-29.0%)
18.38M
est: 305.54M (-94.0%)
-1.03B
— – —
SGA
69.31M
est: 47.22M (+46.8%)
91.54M
est: 104.94M (-12.8%)
128.89M
est: 126.30M (+2.1%)
264.79M
est: 206.89M (+28.0%)
284.27M
est: 213.61M (+33.1%)
370.29M
est: 244.60M (+51.4%)
368.22M
est: 207.17M (+77.7%)
437.08M
est: 288.39M (+51.6%)
443.86M
est: 437.80M (+1.4%)
503.23M
est: 552.75M (-9.0%)
461.55M
est: 574.63M (-19.7%)
451.38M
est: 647.54M (-30.3%)
383.16M
est: 543.43M (-29.5%)
435.39M
est: 595.16M (-26.8%)
686.87M
686.87M – 686.87M
+15.4% YoY
EPS
0.20
est: 0.19 (+2.7%)
0.18
est: 0.18 (-0.9%)
0.20
est: 0.23 (-13.4%)
0.11
est: 0.10 (+6.4%)
0.14
est: 0.12 (+16.8%)
0.19
est: 0.19 (-1.3%)
0.13
est: 0.13 (-2.7%)
0.15
est: 0.16 (-4.3%)
0.12
est: 0.19 (-37.3%)
0.17
est: 0.17 (-1.9%)
0.04
est: 0.20 (-77.6%)
0.14
est: 0.24 (-41.2%)
0.02
est: 0.28 (-94.0%)
-0.96
— – —
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-29 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-28 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-27 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-26 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-22 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-21 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-20 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-19 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-18 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-15 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-14 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-13 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-12 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-11 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-08 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-07 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-06 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-04 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-30 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-29 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-28 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-27 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-24 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-23 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-22 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
-1.34B
OE per share TTM
-1.24
Owner's Yield
-94.42%
Maintenance CapEx ratio
Maint CapEx / Avg PPE
91.9%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
Total invested
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock Held by 1 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 Dimensional World ex U.S. Core Equity 2 ETF DFAX 0.00% 48.8K 0.28%

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
-44.6K
Shares Outstanding
1.08B

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Ming Fan Wang Chief Executive Officer & Executive Chairman 2M male
Qing Long Li Executive Director 2M male
Xinyi Wang Executive Director 2M female
Ying Chun Yang Financial Controller 1M male
Wu Qian Managing Director of Dongguan Boton 1M male
Siu Kit Ma Company Secretary male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits